Alnylam Pharmaceuticals, Inc.

Vanguard Personalized Indexing Management, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

13,727

Value ($000)

5,459

Weight

0.1%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,459	0.1%	13,727	12/31/2025
2025 Q3	10/31/2025	6,380	0.1%	13,985	9/30/2025
2025 Q2	7/25/2025	4,368	0.0%	13,390	6/30/2025
2025 Q1	5/14/2025	2,454	0.0%	9,088	3/31/2025
2024 Q4	2/10/2025	2,018	0.0%	8,574	12/31/2024
2024 Q3	11/12/2024	2,469	0.0%	8,978	9/30/2024
2024 Q2	8/12/2024	1,738	0.0%	7,153	6/30/2024
2024 Q1	5/9/2024	910	0.0%	6,086	3/31/2024
2023 Q4	2/8/2024	1,223	0.0%	6,390	12/31/2023
2023 Q3	11/8/2023	1,016	0.0%	5,735	9/30/2023
2023 Q2	7/28/2023	1,208	0.0%	6,358	6/30/2023
2023 Q1	5/10/2023	1,262	0.0%	6,299	3/31/2023
2022 Q4	2/10/2023	1,567	0.1%	6,592	12/31/2022
2022 Q3	11/14/2022	1,174	0.1%	5,866	9/30/2022
2022 Q2	8/12/2022	652	0.0%	4,468	6/30/2022
2022 Q1	5/16/2022	685	0.0%	4,193	3/31/2022
2021 Q4	2/23/2022	490	0.0%	2,889	12/31/2021
2021 Q3	11/9/2021	463	0.0%	2,451	9/30/2021
2021 Q2	8/11/2021	378	0.0%	2,229	6/30/2021